Digital Prescription Market: 2.64 Billion E-Prescriptions Shift Competition to Accuracy, Transfers and Drug Access

Digital prescribing is increasingly judged by what happens after a prescription is sent: whether it is accurate, reaches the intended pharmacy and clears barriers to treatment. Surescripts reported that its network supported 1.39 million prescribers who sent 2.64 billion electronic prescriptions in 2025. In March 2026, the company said its RxTransfer service was available across 4,800 Walmart locations; pharmacies completed 542,202 transfers in January alone, more than double the total recorded in 2025. The shift from digitizing prescription transmission to connecting pharmacy workflows, cost information and prior authorization is creating a broader competitive field for e-prescribing platforms.

According to DataM Intelligence, the global digital prescription market was valued at US$2.82 billion in 2025 and is forecast to reach US$13.26 billion by 2033, growing at a 21.9% CAGR from 2026 to 2033. The market includes software solutions and related services, delivered through web and cloud-based systems or on-premise platforms. Integrated solutions lead, while web and cloud-based systems are gaining ground through scalability and remote access.

Request Executive Sample: https://www.datamintelligence.com/download-sample/digital-prescription-market?kailas

The commercial opportunity is moving beyond replacing handwritten prescriptions. Pharmacy transfers, renewals, medication history, real-time benefit information and electronic prior authorization can reduce manual follow-up and help care teams identify access barriers earlier. In September 2026, Surescripts and Oracle Health announced plans to make Surescripts' prior-authorization automation available within Oracle Health workflows, with general availability planned for 2027. The companies also plan to explore bringing first-fill abandonment insights into the workflow.

Standards readiness is becoming a product requirement. ONC's HTI-4 rule updates e-prescribing certification criteria, adopts NCPDP SCRIPT Version 2023011 and adds a real-time prescription benefit criterion. Certified health IT developers must support the updated standard by the end of 2027, with the updated certification requirements applying from January 2028. This puts interoperability and upgrade planning alongside usability, security and integration costs in platform decisions.

Recent Developments
- October 6, 2026: Surescripts named its 2026 White Coat Award winners for e-prescription accuracy and performance, reporting 2.64 billion e-prescriptions and 1.39 million prescribers on its network in 2025.

- September 24, 2026: Surescripts and Oracle Health announced a collaboration to integrate prior-authorization automation into Oracle Health workflows, with general availability planned for 2027.

- March 31, 2026: Surescripts reported RxTransfer availability across 4,800 Walmart locations and more than 542,000 pharmacy transfer transactions in January 2026.

Purchase This Exclusive Report: https://www.datamintelligence.com/buy-now-page?report=digital-prescription-market?kailas

Additional Benefits:
✅ Get Interactive Dashboard Access (With No Additional Cost)
✅ Three months of analyst support to answer queries related to the report.

Market Segmentation

By service type, the market includes solutions and services such as implementation, support and maintenance, network services, and training. Integrated software connects prescribing with electronic health records and hospital systems.

By delivery mode, providers can choose web and cloud-based solutions or on-premise systems. Cloud platforms offer remote access and scalability; on-premise deployments remain relevant for organizations with specific security and compliance requirements.

Company Profiles

Surescripts:
Surescripts operates an e-prescribing network connecting electronic health records, prescribers and pharmacies. Its product set includes electronic prescribing, prescription transfer, medication history, real-time prescription benefit and prior-authorization services. The company reported 2.64 billion e-prescriptions on its network in 2025.

Oracle Health:
Oracle Health provides clinical software that includes e-prescribing and medication-management capabilities. Its collaboration with Surescripts is designed to bring prior-authorization automation into the prescriber workflow, with a planned 2027 launch.

DrFirst:
DrFirst offers e-prescribing for private practices, hospitals, health systems and EHR vendors. Its portfolio includes mobile prescribing, controlled-substance workflows, patient engagement and medication-management tools.

athenahealth:
athenahealth provides cloud-based healthcare software, including the athenaOne platform. The company was among the 2026 Surescripts White Coat Award winners for prescription performance, reflecting its participation in network-based e-prescribing workflows.

Digital prescription platforms are expanding from prescription creation and transmission into connected medication-access workflows. Providers that can support standards-based exchange while simplifying pharmacy coordination, benefit checks and authorization processes are positioned to compete as health systems update their prescribing infrastructure.

Identify partners and growth opportunities through DataM Intelligence's market sizing, segmentation and competitive analysis: https://www.datamintelligence.com/partner-identification-enquiry/digital-prescription-market?kailas

Contact Us:
Sai Kiran
Business Development Manager
DataM Intelligence 4market Research LLP
6th Floor, M2 Tech Hub, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
USA: +1 877-441-4866
Email: Sai.k@datamintelligence.com

About DataM Intelligence
DataM Intelligence is a global market research and business intelligence firm delivering actionable insights across healthcare, pharmaceuticals, chemicals, energy, technology, food, and industrial sectors. Through syndicated reports, custom research, consulting, and competitive intelligence services, the company helps organizations identify growth opportunities, navigate market challenges, and make informed strategic decisions in over 50+ countries worldwide.

This release was published on openPR.